Unknown

Dataset Information

0

Sex differences in the pituitary transforming growth factor-?1 system: studies in a model of resistant prolactinomas.


ABSTRACT: Dopamine and estradiol interact in the regulation of lactotroph cell proliferation and prolactin secretion. Ablation of the dopamine D2 receptor gene (Drd2(-/-)) in mice leads to a sexually dimorphic phenotype of hyperprolactinemia and pituitary hyperplasia, which is stronger in females. TGF-?1 is a known inhibitor of lactotroph proliferation. TGF-?1 is regulated by dopamine and estradiol, and it is usually down-regulated in prolactinoma experimental models. To understand the role of TGF-?1 in the gender-specific development of prolactinomas in Drd2(-/-) mice, we compared the expression of different components of the pituitary TGF-?1 system, including active cytokine content, latent TGF-?-binding protein isoforms, and possible local TGF-?1 activators, in males and females in this model. Furthermore, we evaluated the effects of dopamine and estradiol administration to elucidate their role in TGF-?1 system regulation. The expression of active TGF-?1, latent TGF-?-binding protein isoforms, and several putative TGF-?1 activators evaluated was higher in male than in female mouse pituitary glands. However, Drd2(-/-) female mice were more sensitive to the decrease in active TGF-?1 content, as reflected by the down-regulation of TGF-?1 target genes. Estrogen and dopamine caused differential regulation of several components of the TGF-?1 system. In particular, we found sex- and genotype- dependent regulation of active TGF-?1 content and a similar expression pattern for 2 of the putative TGF-?1 activators, thrombospondin-1 and kallikrein-1, suggesting that these proteins could mediate TGF-?1 activation elicited by dopamine and estradiol. Our results indicate that (1) the loss of dopaminergic tone affects the pituitary TGF-?1 system more strongly in females than in males, (2) males express higher levels of pituitary TGF-?1 system components including active cytokine, and (3) estradiol negatively controls most of the components of the system. Because TGF-?1 inhibits lactotroph proliferation, we propose that the higher levels of the TGF-?1 system in males could protect or delay the development of prolactinomas in Drd2(-/-) male mice.

SUBMITTER: Recouvreux MV 

PROVIDER: S-EPMC3800752 | biostudies-literature | 2013 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Sex differences in the pituitary transforming growth factor-β1 system: studies in a model of resistant prolactinomas.

Recouvreux M Victoria MV   Lapyckyj Lara L   Camilletti M Andrea MA   Guida M Clara MC   Ornstein Ana A   Rifkin Daniel B DB   Becu-Villalobos Damasia D   Díaz-Torga Graciela G  

Endocrinology 20130905 11


Dopamine and estradiol interact in the regulation of lactotroph cell proliferation and prolactin secretion. Ablation of the dopamine D2 receptor gene (Drd2(-/-)) in mice leads to a sexually dimorphic phenotype of hyperprolactinemia and pituitary hyperplasia, which is stronger in females. TGF-β1 is a known inhibitor of lactotroph proliferation. TGF-β1 is regulated by dopamine and estradiol, and it is usually down-regulated in prolactinoma experimental models. To understand the role of TGF-β1 in t  ...[more]

Similar Datasets

| S-EPMC7660821 | biostudies-literature
| S-EPMC1866928 | biostudies-literature
| S-EPMC5286726 | biostudies-literature
| S-EPMC4476448 | biostudies-literature
| S-EPMC4942197 | biostudies-literature
| S-EPMC6508935 | biostudies-literature
| S-EPMC8305211 | biostudies-literature
| S-EPMC2586596 | biostudies-literature
| S-EPMC3268397 | biostudies-literature
| S-EPMC3404347 | biostudies-literature